Certara (CERT) vs Heartflow (HTFL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Heartflow (HTFL) has outperformed Certara (CERT) over the past year, gaining 41.1% versus a loss of 30.7%. Heartflow is the larger company by market cap ($4.29 billion vs $1.37 billion), about 3.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERT | HTFL |
|---|---|---|
| Share price | $8.96 | $49.36 |
| Market cap | $1.37B | $4.29B |
| 1-day change | -3.34% | -2.62% |
| YTD return | +1.70% | +69.33% |
| 1-year return | -30.70% | +41.07% |
| 5-year return | -76.32% | — |
| Forward P/E | 23.04 | — |
| EPS (TTM) | $-0.14 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $176.03M |
| Revenue growth (YoY) | — | +39.92% |
| Net income (latest FY) | — | $-116.79M |
| Gross margin | — | 76.80% |
| Operating margin | — | -36.39% |
| Net margin | — | -66.35% |
| 52-week high | $13.30 | $54.32 |
| 52-week low | $4.45 | $20.13 |
| Distance from 52-week high | -32.63% | -9.13% |
| Analyst consensus | buy | none |
| Avg. price target upside | -3.79% | -6.81% |
| Average volume | 3.09M | 1.79M |
| Shares outstanding | 152.54M | 86.95M |
| Employees | 1,515 | 843 |
| Sector | Technology | Health Care |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Heartflow is about 3.1 times larger than Certara by market value ($4.29B vs $1.37B).
- HTFL has outperformed CERT by 71.8 percentage points over the past year.
- The two companies sit in different sectors: Certara in Technology and Heartflow in Health Care.
About Certara
CERT stock →Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.
Technology · Computer Software: Prepackaged Software · 1,515 employees
About Heartflow
HTFL stock →HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.
Health Care · Medical/Dental Instruments · 843 employees
CERT vs HTFL FAQ
Which is bigger, Certara or Heartflow?
Heartflow (HTFL) is larger, with a market capitalization of $4.29B compared with $1.37B for Certara (CERT).
Which stock has performed better over the past year, CERT or HTFL?
HTFL returned +41.07% over the past 12 months, compared with -30.70% for CERT (price return, excluding dividends). Past performance does not predict future results.
Are Certara and Heartflow in the same industry?
No. Certara is in the Technology sector, while Heartflow is in Health Care.